BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

619 related articles for article (PubMed ID: 27161430)

  • 21. Effect of stimulated erythropoiesis on liver SMAD signaling pathway in iron-overloaded and iron-deficient mice.
    Frýdlová J; Rogalsky DW; Truksa J; Nečas E; Vokurka M; Krijt J
    PLoS One; 2019; 14(4):e0215028. PubMed ID: 30958854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iron metabolism and iron disorders revisited in the hepcidin era.
    Camaschella C; Nai A; Silvestri L
    Haematologica; 2020; 105(2):260-272. PubMed ID: 31949017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The erythroid function of transferrin receptor 2 revealed by Tmprss6 inactivation in different models of transferrin receptor 2 knockout mice.
    Nai A; Pellegrino RM; Rausa M; Pagani A; Boero M; Silvestri L; Saglio G; Roetto A; Camaschella C
    Haematologica; 2014 Jun; 99(6):1016-21. PubMed ID: 24658816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The second transferrin receptor regulates red blood cell production in mice.
    Nai A; Lidonnici MR; Rausa M; Mandelli G; Pagani A; Silvestri L; Ferrari G; Camaschella C
    Blood; 2015 Feb; 125(7):1170-9. PubMed ID: 25499454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythropoietic regulators of iron metabolism.
    Ganz T
    Free Radic Biol Med; 2019 Mar; 133():69-74. PubMed ID: 29981834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iron and erythropoiesis: A mutual alliance.
    Silvestri L; Nai A
    Semin Hematol; 2021 Jul; 58(3):145-152. PubMed ID: 34389106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin A deficiency modulates iron metabolism via ineffective erythropoiesis.
    da Cunha MS; Siqueira EM; Trindade LS; Arruda SF
    J Nutr Biochem; 2014 Oct; 25(10):1035-44. PubMed ID: 24998947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A hepcidin lowering agent mobilizes iron for incorporation into red blood cells in an adenine-induced kidney disease model of anemia in rats.
    Sun CC; Vaja V; Chen S; Theurl I; Stepanek A; Brown DE; Cappellini MD; Weiss G; Hong CC; Lin HY; Babitt JL
    Nephrol Dial Transplant; 2013 Jul; 28(7):1733-43. PubMed ID: 23345622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic iron homeostasis and erythropoiesis.
    Papanikolaou G; Pantopoulos K
    IUBMB Life; 2017 Jun; 69(6):399-413. PubMed ID: 28387022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erythroferrone and hepcidin as mediators between erythropoiesis and iron metabolism during allogeneic hematopoietic stem cell transplant.
    Pirotte M; Fillet M; Seidel L; Jaspers A; Baron F; Beguin Y
    Am J Hematol; 2021 Oct; 96(10):1275-1286. PubMed ID: 34310730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hematopoietic deletion of transferrin receptor 2 in mice leads to a block in erythroid differentiation during iron-deficient anemia.
    Rishi G; Secondes ES; Wallace DF; Subramaniam VN
    Am J Hematol; 2016 Aug; 91(8):812-8. PubMed ID: 27169626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The role of erythroferrone in iron metabolism: From experimental results to pathogenesis].
    Vallet N;
    Rev Med Interne; 2018 Mar; 39(3):178-184. PubMed ID: 28666715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant human erythropoietin-induced erythropoiesis regulates hepcidin expression over iron status in the rat.
    Ribeiro S; Garrido P; Fernandes J; Rocha S; Rocha-Pereira P; Costa E; Belo L; Reis F; Santos-Silva A
    Blood Cells Mol Dis; 2016 Jul; 59():63-70. PubMed ID: 27282570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Progress in iron metabolism research].
    Kawabata H
    Rinsho Ketsueki; 2017; 58(10):1864-1871. PubMed ID: 28978826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reciprocal regulation between hepcidin and erythropoiesis and its therapeutic application in erythroid disorders.
    Wang C; Fang Z; Zhu Z; Liu J; Chen H
    Exp Hematol; 2017 Aug; 52():24-31. PubMed ID: 28501597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in hepcidin and reticulocyte hemoglobin equivalent levels in response to continuous erythropoietin receptor activator administration in hemodialysis patients: a randomized study.
    Kakimoto-Shino M; Toya Y; Kuji T; Fujikawa T; Umemura S
    Ther Apher Dial; 2014 Oct; 18(5):421-6. PubMed ID: 24456328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ineffective erythropoiesis and regulation of iron status in iron loading anaemias.
    Camaschella C; Nai A
    Br J Haematol; 2016 Feb; 172(4):512-23. PubMed ID: 26491866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of Hepcidin by Erythropoiesis: The Story So Far.
    Pasricha SR; McHugh K; Drakesmith H
    Annu Rev Nutr; 2016 Jul; 36():417-34. PubMed ID: 27146013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia.
    Kautz L; Jung G; Du X; Gabayan V; Chapman J; Nasoff M; Nemeth E; Ganz T
    Blood; 2015 Oct; 126(17):2031-7. PubMed ID: 26276665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in β-thalassemia.
    Gardenghi S; Grady RW; Rivella S
    Hematol Oncol Clin North Am; 2010 Dec; 24(6):1089-107. PubMed ID: 21075282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.